268 related articles for article (PubMed ID: 29362125)
1. Head and neck squamous cell carcinoma of unknown primary: Outcomes of a pre-defined institutional treatment policy in a region with a high prevalence of skin cancer.
Huo M; Panizza B; Bernard A; Porceddu SV
Oral Oncol; 2018 Feb; 77():43-48. PubMed ID: 29362125
[TBL] [Abstract][Full Text] [Related]
2. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma.
Daniels CP; Bressel M; Corry J; Cole A; Chua MS; Tiong A; Hirshoren N; Dixon B; McDowell L
Pract Radiat Oncol; 2020; 10(1):29-35. PubMed ID: 31606546
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck.
Hung YH; Liu SA; Wang CC; Wang CP; Jiang RS; Wu SH
PLoS One; 2018; 13(10):e0205365. PubMed ID: 30335795
[TBL] [Abstract][Full Text] [Related]
4. Direct skin involvement of cervical lymph node metastasis from mucosal squamous cell carcinoma of the head and neck.
Dragan AD; Nixon IJ; Orabi AA; Manganaris A; Jeannon JP; Guerrero-Urbano MT; Simo R
J Laryngol Otol; 2013 Feb; 127(2):181-6. PubMed ID: 23217250
[TBL] [Abstract][Full Text] [Related]
5. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of disease-free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases.
Ebrahimi A; Clark JR; Ahmadi N; Palme CE; Morgan GJ; Veness MJ
Head Neck; 2013 Aug; 35(8):1138-43. PubMed ID: 23152126
[TBL] [Abstract][Full Text] [Related]
7. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
[TBL] [Abstract][Full Text] [Related]
8. Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma.
Vasan K; Low TH; Gupta R; Ashford B; Asher R; Gao K; Ch'ng S; Palme CE; Clark JR
Head Neck; 2018 May; 40(5):993-999. PubMed ID: 29360276
[TBL] [Abstract][Full Text] [Related]
9. Distant metastasis at the time of presentation of head and neck squamous cell carcinoma: a retrospective chart review from a tertiary cancer care centre.
Majitha CS; Nayak DR; Shetty S; Devaraja K; Basheer JI
J Laryngol Otol; 2024 Jun; 138(6):661-666. PubMed ID: 38131132
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.
Kubota H; Miyawaki D; Mukumoto N; Ishihara T; Matsumura M; Hasegawa T; Akashi M; Kiyota N; Shinomiya H; Teshima M; Nibu KI; Sasaki R
Radiat Oncol; 2021 Jan; 16(1):1. PubMed ID: 33402192
[TBL] [Abstract][Full Text] [Related]
11. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
12. Outcomes in N3 Head and Neck Squamous Cell Carcinoma and Role of Upfront Neck Dissection.
Boros A; Blanchard P; Dade A; Gorphe P; Breuskin I; Even C; Nguyen F; Deutsch E; Bidault F; Janot F; Temam S; Mirghani H; Tao Y
Laryngoscope; 2021 Mar; 131(3):E846-E850. PubMed ID: 32833260
[TBL] [Abstract][Full Text] [Related]
13. Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.
Tanvetyanon T; Padhya T; McCaffrey J; Kish JA; Deconti RC; Trotti A; Rao NG
Head Neck; 2015 Jun; 37(6):840-5. PubMed ID: 24623654
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of nodal metastatic cutaneous squamous cell carcinoma of the head and neck treated in a regional center.
Schmidt C; Martin JM; Khoo E; Plank A; Grigg R
Head Neck; 2015 Dec; 37(12):1808-15. PubMed ID: 24995842
[TBL] [Abstract][Full Text] [Related]
15. Distant metastases in head and neck cancer.
Duprez F; Berwouts D; De Neve W; Bonte K; Boterberg T; Deron P; Huvenne W; Rottey S; Mareel M
Head Neck; 2017 Sep; 39(9):1733-1743. PubMed ID: 28650113
[TBL] [Abstract][Full Text] [Related]
16. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Oligometastatic Disease in Squamous Cell Carcinoma of the Head and Neck.
Vincent AG; Wang W; Shokri T; Ducic Y
Laryngoscope; 2021 May; 131(5):E1476-E1480. PubMed ID: 33044014
[TBL] [Abstract][Full Text] [Related]
18. Metastatic head and neck cutaneous squamous cell carcinoma: defining a low-risk patient.
Ebrahimi A; Clark JR; Lorincz BB; Milross CG; Veness MJ
Head Neck; 2012 Mar; 34(3):365-70. PubMed ID: 21472887
[TBL] [Abstract][Full Text] [Related]
19. Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes.
Amoils M; Lee CS; Sunwoo J; Aasi SZ; Hara W; Kim J; Sirjani D; Colevas AD; Chang AL; Divi V
Head Neck; 2017 May; 39(5):881-885. PubMed ID: 28252823
[TBL] [Abstract][Full Text] [Related]
20. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
